Evidence map›Paper›PMID 33740019›Full record

ArticlePloS one2021

Synergistic metalloproteinase-based remodeling of matrix by pancreatic tumor and stromal cells.

Hong Cao, Li Qiang, Jing Chen, Katherine M Johnson, Mark A McNiven, Gina L Razidlo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hong CaoDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Li QiangDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Jing ChenDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Katherine M JohnsonDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Mark A McNivenDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.ORCID 0000-0002-9830-1885
Gina L RazidloDivision of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America.
Mayo Clinic · US

Funding

Tissue CoreP50CA102701 · NCI · MAYO CLINIC ROCHESTER · PI MUKHOPADHYAY, DEBABRATA · 2004 to 2018
$32.7M
TARGETING EARLY CHANGES FOR NEW SCREENING STRATEGIESP50CA058184 · NCI · JOHNS HOPKINS UNIVERSITY · PI HERMAN, JAMES G. · 1992 to 2013
$30.5M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI Nicholas F. LaRusso · 2009 to 2026
$22.2M
Cytoskeletal Dynamics in Pancreatic Cancer MetastasisR01CA104125 · NCI · MAYO CLINIC ROCHESTER · PI MC NIVEN, MARK A., RAZIDLO, GINA LYNN · 2004 to 2019
$4.2M
NCI NIH HHS P50 CA058184NCI NIH HHS P50 CA102701NCI NIH HHS R01 CA104125NIDDK NIH HHS P30 DK084567
6 · The paper itself

Abstract

The process by which tumor cells mechanically invade through the surrounding stroma into peripheral tissues is an essential component of metastatic dissemination. Matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation plays an important role in this invasive process. Defining the contribution and interaction between these MMPs during invasion remains a key interest in the development of targeted anti-metastatic therapies. In this study we have utilized multiple different stromal fibroblasts and tumor cells to define the relative contributions between cancer cells and stromal cells during MMP-dependent matrix remodeling and pancreatic (PDAC) tumor cell invasion. We find that tumor cells co-cultured with the conditioned medium from stromal fibroblasts exhibited a substantial increase in invadopodial-based matrix degradation and transwell invasion. This increase is dependent on pro-MMP2 expressed and secreted by stromal fibroblasts. Further, the pro-MMP2 from the stromal fibroblasts is activated by MT1-MMP expressed on the tumor cells. Depletion of MT1-MMP, the known activator of MMP2, in tumor cells largely blocked matrix remodeling, even in the presence of stromal cell medium. In summary, these findings implicate an important interplay between MT1-MMP from tumor cells and MMP2 from fibroblasts as a key component for ECM remodeling and invasion.

Indexed as

Cell LineCell Line, TumorCell MovementExtracellular MatrixFibroblastsHumansMatrix MetalloproteinasesNeoplasm InvasivenessPancreatic NeoplasmsStromal CellsMatrix Metalloproteinases

Identifiers

PMID33740019
PMCPMC7978280
OpenAlexW3136123731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.